1993
Rifabutin Approval HHS News - December 23, 1992 U.S. Department of Health and Human Services, Food and Drug Administration
Trimetrexate Approved For Treatment of PCP FDA Press Release - December 20, 1993 Food and Drug Administration
Fluconazole Delays Fungal Infections In AIDS Patients News from NIAID - December 15, 1993 National Institute of Allergy and Infectious Diseases
Primary Therapy Prevents Initial Bout of PCP News from NIAID - December 15, 1993 ND: 931215 National Institute of Allergy and Infectious Diseases
Acyclovir-Resistant Genital Herpes Found in Person with Healthy Immune System News from NIAID - December 8, 1993 National Institute of Allergy and Infectious Diseases, National Institutes of Health
CDC Questions and Answers ... HIV Transmission in Household Settings CDC Fact Sheet - December 4, 1993 Centers for Disease Control and Prevention
HIV Transmission in Household Settings CDC Fact Sheet - December 4, 1993 Centers for Disease Control and Prevention
HIV Prevention -- Bringing the Message Home CDC Fact Sheet - December 3, 1993 Centers for Disease Control and Prevention
HIV Therapy Recommendations Issued News from NIAID - December 1, 1993 National Institute of Allergy and Infectious Diseases, National Institutes if Health
ACTG Assessment: Organization and Management ACTG Assessment - December, 1993 ND: 931200 National Institute of Allergy and Infectious Diseases, National Institutes of Health
Future NIAID AIDS Treatment Strategies Will Be Based on Greater Understanding of HIV Disease Mechanisms News from NIAID - November 11, 1993 National Institute of Allergy and Infectious, National Institutes of Health
Parasites in the United States Affect Millions News from NIAID - November 1, 1993 National Institute of Allergy and Infectious Diseases, National Institutes of Health
Fauci: AIDS Therapies Must Address Complexity of HIV Disease Process News from NIAID - October 18, 1993 ND: 931018 National Institute of Allergy and Infectious Diseases, National Institutes of Health
Researchers Examine Possible Effects of Silicone on the Immune Response News from NIAID - October 17, 1993 National Institute of Allergy and Infectious Diseases, National Institutes of Health
NIAID HIV Vaccine Trials Update News from NIAID - October 10, 1993 ND: 931010 National Institute of Allergy and Infectious Diseases, National Institutes of Health
AIDS Vaccines Contracts Pave Way for Large National and International Studies News from NIAID - October 10, 1993 ND: 931010 National Institute of Allergy and Infectious Diseases
Nine U.S. Sites Selected For Study of Early, Primary HIV Infection News from NIAID - October 5, 1993 National Institute of Allergy and Infectious Diseases, National Institutes of Health
Facts About AIDS in the Workplace AIDS IN THE WORKPLACE FACT SHEET - October 1993 Centers for Disease Control and Prevention: Business Responds to AIDS
NIAID: Drug Rifabutin Should Be Used to Prevent MAC News from NIAID - September 15, 1993 National Institute of Allergy and Infectious Diseases
Task Force Issues Prevention and Treatment Recommendations for AIDS- related MAC News from NIAID - September 15, 1993 ND: 930915 National Institute of Allergy and Infectious Diseases, National Institutes of Health
Questions and Answers Concerning MMWR Article on Condom Effectiveness CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #60 - August 4, 1993 Centers for Disease Control and Prevention
Statement Concerning Condom Use CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #59 - August 3, 1993Centers for Disease Control and Prevention
Answers to Questions From CDC National AIDS Hotline Information Specialists Concerning Disinfection of Needles and Syringes With Bleach CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #58 - August 3, 1993 Centers for Disease Control and Prevention
Facts About ... Condoms and Their Use in Preventing HIV Infection and Other STDs HIV / AIDS PREVENTION FACTSHEET - July 30, 1993 Centers for Disease Control and Prevention
Two Studies Examine Drugs to Prevent HIV-Associated Opportunistic Infections News from NIAID - July 26, 1993 National Institute of Allergy and Infectious Diseases, National Institutes of Health
Proposals to Enhance the Safety of the Blood Supply FDA News Release - July 1, 1993 ND: 930701 Department of Health and Human Services
Immunity Without T Cells: NIAID Researchers Illuminate Role of Interleukin-12 News from NIAID - June 30, 1993National Institute of Allergy and Infectious Diseases, National Institutes of Health
Update of Criteria Used to Evaluate Disability Claims Filed by Individuals with HIV Infection and Other Immune System Disorders: Part One of Two HHS NEWS - June 29, 1993Department of Health and Human Services, Social Security Administration
Statement Concerning Preliminary HIV Therapy Guidelines CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #57 - June 29, 1993 National Institutes of Health
ACTG Minority Sites Funded, Pediatric ACTGs Renewed HHS News - June 28, 1993 U.S. Department of Health and Human Services, National Institutes of Health
Women's Interagency HIV Study Begins. HHS News - June 28, 1993 ND: 930628 U.S. Department of Health and Human Services
Answers to Questions From CDC National AIDS Hotline Information Specialists Concerning Testing for HIV Infection CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #56 - June 25, 1993 Centers for Disease Control and Prevention
HIV Therapy Guidelines Issued News from NIAID - June 25, 1993 National Institute of Allergy and Infectious Diseases, National Institutes of Health
Statement Concerning Pediatric AIDS Cases With Undetermined Risk CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #55 - June 23, 1993 Centers for Disease Control and Prevention
'Female Condom' Approved FDA Bulletin - June 22, 1993 Department of Health and Human Services, Food and Drug Administration
Glass Capillary Tubes Pose Risk to Health Care Workers FDA Bulletin - June 22, 1993 Department of Health and Human Services, Food and Drug Administration
New Labeling to Provide Information About Contraceptives and STDs FDA Bulletin - June 22, 1993 Department of Health and Human Services, Food and Drug Administration
Syndrome of CD4+ T Cell Suppression Without HIV Infection Rare, Occurs in Many Forms News from NIAID - June 11, 1993 ND: 930611 National Institute of Allergy and Infectious Diseases, National Institutes of Health
Your Rights as a Person With HIV Infection, AIDS, or Related Conditions: In Federally Funded Health and Human Service Programs HHS Fact Sheet - June 10, 1993U.S. Department of Health and Human Services, Office for Civil Rights
U.S. Surgeon General's Report Released HHS Press Release - June 10, 1993 U.S. Department of Health and Human Services
The Effectiveness of AZT Alone, ddC Alone or AZT/ddC Combination Is Similar Overall For Patients with Advanced HIV Disease News from NIAID - June 10, 1993 ND: 930610 National Institute of Allergy and Infectious Diseases, National Institutes of Heath
Relative Benefit of ddI and AZT Depends on Duration of Patients' Previous AZT Use News from NIAID - June 10, 1993 National Institute of Allergy and Infectious Diseases, National Institutes of Health
Trial of TAT Antagonist as Therapy for HIV Infection Altered News from NIAID - June 10, 1993 National Institute of Allergy and Infectious Diseases, National Institutes of Health
EEOC Files Lawsuit Against Insurance Plan That Excludes Coverage For Individual With AIDS EEOC Press Release - June 9, 1993U.S. Equal Employment Opportunity Commission
NIAID Combats Tuberculosis on Many Fronts News from NIAID - June 9, 1993 National Institute of Allergy and Infectious Diseases, National Institutes of Health
Young Gay Men Not Heeding AIDS Message, Rates of Infection Remains High News from NIAID - June 9, 1993 ND: 930609 National Institute of Allergy and Infectious Diseases, National Institutes of Health
Interim Enforcement Guidance on the Application of the ADA to Disability-Based Provisions of Employer-Provided Health Insurance EEOC Press Release - June 8, 1993 U.S. Equal Employment Opportunity Commission
ACTG 116B/117: High Levels of AZT Resistance May Predict HIV Disease Progression News from NIAID - June 8, 1993 National Institute of Allergy and Infectious Diseases, National Institutes of Health
AIDS Survival Time Nearly Doubles Since 1984 News from NIAID - June 8, 1993 National Institute of Allergy and Infectious Diseases, National Institutes of Health
AIDS Treatment Strategies Must Address Multi-Dimensional Nature of HIV Disease News from NIAID - June 7, 1993 National Institute of Allergy and Infectious Diseases, National Institutes of Health
President Called to Lead National Response to AIDS in the Workplace National Leadership Coalition on AIDS News Release - June 1, 1993 National Leadership Coalition on AIDS
Statement Concerning the Use of Atovaquone as a Treatment for AIDS-Related Pneumonia CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #54 - June 1, 1993 National Institutes of Health
AIDS and Opportunistic Infections NIAID Backgrounder - June 1993 National Institute of Allergy and Infectious Diseases
HIV and AIDS Research IX International Conference on AIDS Highlights Tipsheet for Science Writers - June 1993 HIV and AIDS Research IX International Conference on AIDS Highlights
Women and HIV, IX International Conference on AIDS Highlights Tipsheet for Science Writers - June 1993 National Institute of Allergy and infectious Diseases, National Institutes of Health
Clinical Trials of HIV/AIDS Vaccines IX International Conference on AIDS Highlights Tipsheet for Science Writers - June 1993 ND: 930600 National Institute for Allergy and Infectious Diseases, National Institutes of Health
HIV Infection Among Gay and Bisexual Men IX International Conference on AIDS Highlights Tipsheet for Science Writers - June 1993National Institute of Allergy and Infectious Diseases, National Institutes of Health
Answers to Questions Asked by CDC National AIDS Hotline Information Specialists Concerning the CDC Revised AIDS Case Definition CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #53 - May 28, 1993 Centers for Disease Control and Prevention
Atovaquone Effective, Well-Tolerated Treatment for AIDS-Related Pneumonia News from NIAID - May 26, 1993 National Institute of Allergy and Infectious Diseases, National Institutes of Health
Statement Concerning Clinical Trial of Acupuncture and Amitriptyline for Pain Relief CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #52 - May 25, 1993 National Institutes of Health
Statement Concerning Trial of Three-Drug Combination Therapy for HIV Infection CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #51 - May 25, 1993 National Institutes of Health
Approval of supplemental application for streptomycin sulfate.Press Release - May 17, 1993 U.S. Department of Health and Human Services, Food and Drug Administration
Statement on HIV / AIDS and Health Care Workers CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #50 - May 7, 1993 Centers for Disease Control and Prevention
Statement Concerning Clinical Trials of Therapeutic AIDS Vaccines in Pregnant Women CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #49 - May 6, 1993 National Institutes of Health
First clinical trials of AIDS vaccine in HIV infected pregnant women. HHS News - May 6, 1993 U.S. Department of Health and Human Services, National Institutes of Health
Statement on the Role of Bleach in HIV Prevention Programs for Injecting Drug Users (IDUs) CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #48 - May 5, 1993 Centers for Disease Control and Prevention. National Institutes of Drug Abuse. Center for Substance Abuse.
Questions and Answers Concerning the Impact of the 1993 AIDS Surveillance Case Definition CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #47 - May 3, 1993 Centers for Disease Control and Prevention
Facts About ... HIV / AIDS and Health Care Workers CDC HIV / AIDS Prevention Factsheet - May 1993 Centers for Disease Control and Prevention
Statement Concerning Pediatric AIDS Cases With Undetermined Risk CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #46 - April 21, 1993 Centers for Disease Control and Prevention
Statement Concerning "Lookback" Investigations of the Risk of HIV Transmission From an Infected Health Care Worker to a Patient CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #45 - April 14, 1993 Centers for Disease Control and Prevention
Statement Concerning the Impact of HIV Infection and AIDS On Racial and Ethnic Minorities CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #44 - April 8, 1993 Centers for Disease Control and Prevention
Statement Concerning Study of TB Treatments for Persons Infected With Both HIV and TB CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #43 - April 5, 1993 National Institutes of Health
Johns Hopkins gets research grant. Press Release - April 5, 1993 ND: 930405 U.S. Department of Health and Human Services, Public Health Service
FDA Plans Policy Change on Women in Clinical Trials News Release - April 5, 1993 U.S. Department of Health and Human Services, Food and Drug Administration
Grant to John's Hopkins University to evaluate the effectiveness and appropriate use of AZT, ddI, and other drugs. Press Release - April 5, 1993 U.S. Department of Health and Human Services, Public Health Service
First Large U.S. Study of TB Therapy For HIV-Infected Launched HHS News - April 5, 1993 U.S. Department of Health and Human Services, National Institutes of Health
Statement Concerning Study of U-90,152 CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #42 - April 2, 1993 National Institutes of Health
Statement Concerning the Launch of an HIV Therapy Trial of Protease Inhibitor CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN # 41 - April 2, 1993 National Institutes of Health
Statement Concerning Research on Progression of HIV Disease During Clinical Latency CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #40 - April 2, 1993 National Institutes of Health
Statement Concerning a Trial of Therapeutic Vaccines in HIV Infected Children CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #39 - April 2, 1993 National Institutes of Health
Partial Results of AZT Study Reported in Lancet FDA Talk Paper - April 2, 1993 Food and Drug Administration
Tuberculosis (with article: NIAID Research Agenda for Tuberculosis) NIAID Backgrounder - April 1993National Institute of Allergy and Infectious Diseases
Statement Concerning a Letter About the Use of Bleach in Health Care Settings CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #38 - March 30, 1993 Centers for Disease Control and Prevention
First HIV Vaccine Therapy Trial Begins In HIV-Infected Children HHS News - March 30, 1993 U.S. Department of Health and Human Services, National Institutes of Health
Statement on CD4+ T Cell Suppression Among People Without HIV Infection CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #29 - March 29, 1993 National Institutes of Health
NIAID Launches HIV Therapy Trial of Protease Inhibitor News from NIAID - March 26, 1993 National Institute of Allergy and Infectious Diseases, National Institutes of Health
Proposed Recommendations to Prevent HIV Transmission by Sharing Drug Injection Equipment NIDA Community Alert Bulletin - March 25, 1993 National Institute on Drug Abuse
Questions and Answers Concerning HIV Infection and AIDS Asked by Information Specialists at the CDC National AIDS Hotline CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #37 - March 25, 1993 Centers for Disease Control and Prevention
Statement Concerning Adolescents and HIV / AIDS CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #36 - March 19, 1993 Centers for Disease Control and Prevention
Statement Concerning a Letter in Nature Magazine CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #35 - March 9, 1993 Centers for Disease Control and Prevention
Statement Concerning New Clinical Consultation Service CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #34 - March 9, 1993 Department of Health and Human Services.
Statement Concerning Expansion of the ACTG Candidate Site List for a Proposed HIV Combination Drug Therapy Trial CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #33 - March 5, 1993 National Institutes of Health.
Statement Concerning the Results of a Trial of ddI in Patients Intolerant of AZT CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #32 - March 4, 1993 National Institutes of Health
Government recommends hospitals offer HIV test HHS News - March 4, 1993 U.S. Department of Health and Human Services
First clinical consultation service announced. HHS NEWS - March 4, 1993 U.S. Department of Health and Human Services
Questions and Answers Concerning HIV Transmission CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #31 - March 2, 1993 Centers for Disease Control and Prevention
Facts about ... HIV / AIDS And Race / Ethnicity CDC HIV / AIDS Prevention Factsheet - March 1993Centers for Disease Control and Prevention
Statement on Treatment of HIV Positive Persons Intolerant of Zidovudine Therapy CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #30 - March 1, 1993 National Institutes of Health
Second Recombinant Antihemophilic Factor Licensed HHS News Release - March 1, 1993 U.S Department of Health and Human Services, Food and Drug Administration
Heat Sterilization of Dental Handpieces FDA Medical Bulletin - March 1993 Food and Drug Administration
Results of Trial of ddI in Patients Intolerant of AZT AnnouncedNews from NIAID - February 26, 1993National Institute of Allergy and Infectious Diseases, National Institutes of Health
Statement on New Peptide Vaccine CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #28 - February 24, 1993National Institutes of Health
Questions and Answers on HIV / AIDS and Women CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #27 - February 22, 1993Centers for Disease Control and Prevention
Questions and Answers on the Scope of the HIV / AIDS Epidemic in the United States CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #26 - February 22, 1993Centers for Disease Control and Prevention
Statement on HIV Transmission CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN - February 22, 1993 Centers for Disease Control and Prevention
Questions and Answers on HIV / AIDS and Health Care Workers CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN - February 22, 1993 Centers for Disease Control and Prevention
Statement on the Role of Condoms in Preventing HIV Infection and Other Sexually Transmitted Diseases CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #23 - February 22, 1993Centers for Disease Control and Prevention
NIAID Begins First Test of Novel HIV Peptide Vaccine News from NIAID - February 12, 1993 National Institute of Allergy and Infectious Diseases, National Institutes of Health
Features of CD4+ T Cell Suppression Identified Among People Without HIV Infection News from NIAID - February 10, 1993National Institute of Allergy and Infectious Diseases, National Institutes of Health
Facts about ... Adolescents and HIV / AIDS CDC HIV / AIDS Prevention Factsheet - February 1993Centers for Disease Control and Prevention
Clinical Alert: Important Therapeutic Information on Treatment of HIV Infection in HIV-Infected Patients Who Are Intolerant of or Have Failed Zidovudine Therapy A Note to Physicians - February 1, 1993National Institute of Allergy and Infectious Diseases, National Institutes of Health
Important Therapeutic Information on Treatment of HIV Infection in HIV-Infected Patients Who Are Intolerant of Or Have Failed Zidovudine Therapy National Institute of Allergy and Infectious Diseases, National Institutes of Health - February 1, 1993 A Note to Physicians
Facts About...The Role of Condoms in Preventing HIV Infection and Other Sexually Transmitted Diseases HIV / AIDS PREVENTION FACTSHEET - February 1993 Centers for Disease Control and Prevention
Facts About...Women and HIV / AIDS HIV / AIDS PREVENTION FACTSHEET - February 1993 Centers for Disease Control and Prevention
Facts About...The Human Immunodeficiency Virus and Its Transmission HIV / AIDS PREVENTION FACTSHEET - February 1993 Centers for Disease Control and Prevention
Facts About...The Scope of the HIV / AIDS Epidemic in the United States HIV / AIDS PREVENTION FACTSHEET - February 1993 ND: 930200 Centers for Disease Control and Prevention
Questions and Answers on Latex Condoms CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #22 - January 28, 1993 Centers for Disease Control and Prevention
Patients' Own Immune Cells Used in Experimental HIV Therapy News from NIAID - January 4, 1993 National Institute of Allergy and Infectious Diseases, National Institutes of Health
Questions and Answers on 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #20 - December 31, 1992Centers for Disease Control and Prevention
Relative Benefit of ddI and AZT Depends on Duration of Patients' Previous AZT Use News from NIAID - December 30, 1992 National Institute of Allergy and Infectious Diseases, National Institutes of Health
TMP/SMX Better than Aerosolized Pentamidine for Preventing Recurrent PCP News from NIAID - December 23, 1992National Institute of Allergy and Infectious Diseases, National Institutes of Health
FDA Approves New Indication For Dronabinol FDA Talk Paper - December 23, 1992 Food and Drug Administration
Questions and Answers on Vaginal Yeast Infections and HIV / AIDS CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #19 - December 17, 1992Centers for Disease Control and Prevention
1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults. Morbidity and Mortality Weekly Report - December 18, 1992 Centers for Disease Control and Prevention
Statement On HIV / AIDS and Health - Care Workers CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #18 - December 7,1992Centers for Disease Control and Prevention
First HIV Vaccines Move Into Phase II Testing In Uninfected VolunteersNews Release - December 1, 1992 National Institute of Allergy and Infectious Diseases, National Institutes of Health
Facts About...HIV / AIDS and Health Care Workers HIV / AIDS PREVENTION FACTSHEET - December 1992 Centers for Disease Control and Prevention
Multi-Site Trial Begins of the Anti-AIDS Drug, Tat Antagonist News Release - November 30, 1992National Institute of Allergy and Infectious Diseases, National Institutes of Health
Atovaquone Receives Approval for Treatment of PCP FDA Talk Paper - November 27, 1992Food and Drug Administration
Questions and Answers on HIV Transmission and Dental Procedures CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #17 - November 25, 1992Centers for Disease Control and Prevention
Facts About...The Scope of the HIV / AIDS Epidemic in the United States HIV / AIDS PREVENTION FACTSHEET - November 1992Centers for Disease Control and Prevention
Statement on New Proposed AIDS Surveillance Case Definition CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #16 - October 29, 1992 Centers for Disease Control and Prevention
First AIDS Drug Tested Under Parallel Track Policy; other d4T related press releases FDA Talk Paper - October 5, 1992 Food and Drug Administration
DDI Receives Additional Approval FDA Talk Paper - October 1, 1992 Food and Drug Administration
Facts About...Women and HIV / AIDS HIV / AIDS PREVENTION FACTSHEET - August 1992 Centers for Disease Control and Prevention
Facts About...HIV / AIDS And Race/EthnicityHIV / AIDS PREVENTION FACTSHEET - August 1992Centers for Disease Control and Prevention
Facts About...Adolescents and HIV / AIDS HIV / AIDS PREVENTION FACTSHEET - September 1992 Centers for Disease Control and Prevention
Switch To ddI From AZT Appears to Slow Progression of HIV Disease NIAID Update - August 26, 1992National Institute of Allergy and Infectious Diseases, National Institutes of Health
Questions and Answers on MMWR Article on Nuclear Medicine Procedures CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #15 - August 7, 1992 Centers for Disease Control and Prevention
Facts About...The Centers for Disease Control's (CDC) HIV / AIDS Prevention Activities HIV / AIDS PREVENTION FACTSHEET - August 1992 ND: 920800 Centers for Disease Control and Prevention
Questions and Answers on MMWR Article "Unexplained CD4 T- Lymphocyte Depletion in Persons Without Evident Human Immunodeficiency Virus Infection--United States" CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #14 - July 31, 1992 Centers for Disease Control and Prevention
Statement on HIV - Negative Persons With Low CD4 Counts CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #12 - July 20, 1992 Centers for Disease Control and Prevention
Epidemiologic Notes and Reports: Unexplained CD4+ T-Lymphocyte Depletion in Persons Without Evident HIV Infection -- United States. Morbidity and Mortality Weekly Report, 7/31/92, Vol. 41, No. 30 CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #13 - July 31, 1992 Centers for Disease Control and Prevention
Questions and Answers On Holes in Condoms CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #11 - July 1, 1992 Centers for Disease Control and Prevention
WHERE DO AIDS DRUGS COME FROM? Drug Discovery, Drug Development, and Clinical Trials News Release - July 1992 National Institute of Allergy and Infectious Diseases
Testing AIDS Vaccines: What Do All Those Terms Mean? NIAID Backgrounder - July, 1992 National Institute of Allergy and Infectious Diseases, National Institutes of Health
Approval of zalcitabine. HHS News - June 22, 1992 U.S. Department of Health and Human Services, Food and Drug Administration
Questions and Answers on HIV-2 Infection CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #10 - June 18, 1992 Centers for Disease Control and Prevention
Questions and Answers on Vaginal Yeast Infections CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #9 - June 2, 1992 Centers for Disease Control and Prevention
Questions and Answers on Vaccines, Therapeutic Vaccines, and Immunomodulators CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #8 - May 27, 1992 Centers for Disease Control and Prevention
Questions and Answers on 10-Minute HIV Diagnostic Test Kit CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #7 - May 27, 1992 Centers for Disease Control and Prevention
Statement Concerning Vasectomies and HIV Transmission CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #6 - May 22, 1992 Centers for Disease Control and Prevention
Questions & Answers on HIV Transmission in Health-Care Settings CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #5 - May 15, 1992 Centers for Disease Control and Prevention
Advisory Committee Recommends Approval of ddC as Combination AIDS Therapy FDA Talk Paper - April 21, 1992 Food and Drug Administration
Early Use of AZT Reduces Risk of Death NIAID Update DT: April 15, 1992 ND: 920415 National Institute of Allergy and Infectious Diseases, National Institutes of Health
Summary of Preliminary Analysis of Study Comparing ddI and ZDVNIAID UPDATE - April 13, 1992 ND: National Institute of Allergy and Infectious Diseases, National Institutes of Health
Questions and Answers Concerning MMWR Article "Apparent Transmission of HIV Infection in a Child Receiving Intravenous Therapy" CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #3 - April 10, 1992 ND: 920410 Centers for Disease Control and Prevention
Statement Concerning Transfusions and HIV / AIDS CDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #2 - April 10, 1992 Centers for Disease Control and Prevention
FDA Statement: Revised Recommendations for the Prevention of Human Immunodeficiency Virus (HIV) Transmission by Blood and Blood ProductsCDC NATIONAL AIDS HOTLINE TRAINING BULLETIN - April 1992Food and Drug Administration
Executive Summary AIDS Research Advisory Committee National Institute of Allergy & Infectious Diseases News Release - April 1992 National Institute of Allergy and Infectious Diseases, National Institutes of Health
Study Shows Promise of Fluconazole for Treatment of AIDS-Related Cryptococcal Meningitis NIAID Update - January 8, 1992National Institute of Allergy and Infectious Diseases, National Institutes of Health
ACTG 106: AZT/ddC Combination Shows Benefits for Patients with Advanced HIV Disease NIAID Update - December 31, 1991 National Institute of Allergy and Infectious Diseases, National Institutes of Health
AZT Effective in Minorities and Women, New Analysis Shows NIAID Update - November 20, 1991 National Institute of Allergy and Infectious Diseases, National Institutes of Health
566C80 Receives Treatment IND Status for AIDS Related Use FDA Talk Paper - November 12, 1991 Food and Drug Administration
Important Therapeutic Information on Prevention of Recurrent Pneumocystis Carinii Pneumonia in Persons with AIDS Note to Physicians - October 11, 1991 National Institute of Allergy and Infectious Diseases
HHS Secretary Louis W. Sullivan announces FDA's approval of ddI. HHS NEWS - October 9, 1991 U.S. Department of Health and Human Services, Food and Drug Administration
Foscarnet Approved News Release - September, 27, 1991 Food and Drug Administration
AIDS Vaccine Research AIDS Vaccine Research - August, 1991 National Institute of Allergy and Infectious Diseases, National Institutes of Health
OPPORTUNISTIC INFECTIONS (Part 2): AIDS-Related Cryptococcal Meningitis, Toxoplasmic Encephalitis, AIDS-Related Herpes Simplex Virus Infection, AIDS-Related Cryptosporidiosis, NIAID-Supported Preclinical and Clinical Research OI Backgrounder - May 1991 National Institute of Allergy and Infectious Diseases
OPPORTUNISTIC INFECTIONS (Part 1): Pneumocystis Carinii Pneumonia, CMV Retinitis, AIDS-Related Fungal Illnesses, AIDS-Related Disseminated Histoplasmosis OI Backgrounder - May 1991 National Institute of Allergy and Infectious Diseases
Statement on the Use of Condoms and Spermicides for HIV PreventionCDC NATIONAL AIDS HOTLINE TRAINING BULLETIN #1 - April 23, 1991 Centers for Disease Control and Prevention
Facts and Trends About the HIV / AIDS Epidemic CDC HIV / AIDS PREVENTION FACT SHEET - October 1993 Centers for Disease Control and Prevention
This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1998. AEGIS.